Advances in Parkinson's Disease

Volume 8, Issue 3 (August 2019)

ISSN Print: 2169-9712   ISSN Online: 2169-9720

Google-based Impact Factor: 1.36  Citations  

Evaluation of Clinical Utility of the Personal KinetiGraph® in the Management of Parkinson Disease

HTML  XML Download Download as PDF (Size: 4124KB)  PP. 42-61  
DOI: 10.4236/apd.2019.83005    1,489 Downloads   3,559 Views  Citations

ABSTRACT

INTRODUCTION: Parkinson’s disease (PD) is a disorder characterized by complex motor and non-motor symptoms that can be difficult for patients to accurately communicate. Wearable technologies portend improvements in assessment and monitoring of these symptoms, with their clinical utility currently being evaluated in routine clinical care. OBJECTIVE: To evaluate the clinical utility of the Personal KinetiGraph? (PKG?) Movement Recording System in the routine clinical care of persons with PD (PWP). METHODS: Clinically stable, non-demented PWP presented for two routine clinic visits that included: medication review, symptom review, neurological examination including the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III/IV, and completion of a clinical management plan by a movement disorder specialist prior to review of the PKG report. After reviewing the PKG report, the clinician completed a modified clinical management plan taking into consideration the findings of the PKG. This was repeated at a second visit to evaluate various outcome measures following PKG-enhanced management. RESULTS: The PKG improved the assessment of PD symptoms and the response to treatment, while increasing patient activity levels and compliance. Clinical management plans enhanced by PKG led to different recommendations in 29.4% of cases compared with standard of care due to higher rates of bradykinesia, dyskinesia, tremor, and fluctuations identified by PKG. Using the PKG in the clinical management plan led to a change in medications in 75% (21/28) of patients and both a statistically significant difference and a clinically meaningful reduction in MDS-UPDRS III score of 4.8 (p = 0.028). Additionally, positive changes in both the clinician (17/28; 61%) and patient-reported (13/24; 54%) Global Impression of Improvement were reported. CONCLUSION: The PKG is a valuable tool in augmenting clinical management when utilized along with a clinical assessment.

Share and Cite:

Nahab, F. , Abu-Hussain, H. and Moreno, L. (2019) Evaluation of Clinical Utility of the Personal KinetiGraph® in the Management of Parkinson Disease. Advances in Parkinson's Disease, 8, 42-61. doi: 10.4236/apd.2019.83005.

Cited by

[1] Closing the loop for patients with Parkinson disease: where are we?
Nature Reviews …, 2022
[2] A New Paradigm in Parkinson's Disease Evaluation With Wearable Medical Devices: A Review of STAT-ONTM
Martín, J Cabestany… - Frontiers in …, 2022
[3] Towards the integration of body-worn sensors in the management of Parkinson's disease: perspectives on new paradigms of follow-up
2021
[4] 帕金森病冲动控制障碍的 Scoping 综述
中国康复理论与实践, 2021
[5] Improving Medication Regimen Recommendation for Parkinson's Disease Using Sensor Technology
2021
[6] Optimizing Patient-Specific Medication Regimen Policies Using Wearable Sensors in Parkinson's Disease
Preprint, 2021
[7] Predicting Parkinson's Disease Medication Regimen Using Sensor Technology
2020
[8] Comparing objective and subjective measures of Parkinson's disease using the Parkinson's KinetiGraph
2020

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.